Hyperalgesia and opioid switching

  title={Hyperalgesia and opioid switching},
  author={Sebastiano Mercadante and Edoardo Arcuri},
  journal={American Journal of Hospice and Palliative Medicine},
  pages={291 - 294}
  • S. MercadanteE. Arcuri
  • Published 1 July 2005
  • Medicine, Psychology
  • American Journal of Hospice and Palliative Medicine
Opioids, intended to abolish pain, can unexpectedly produce hyperalgesia, particularly during rapid opioid escalation. Opioid switching could be a therapeutic option in a condition of opioid-induced tolerance or hyperalgesia, but conversion ratios between opioids are difficult to apply in this context and require strict surveillance and expertise. This situation is challenging, because the rapid escalation of opioid doses, possibly due to the development of opioid-induced tolerance, can cause… 

Opioid-Induced Tolerance and Hyperalgesia

Interventional techniques able to decrease the pain input may allow a decrease in the opioid dose, thus reverting the mechanisms producing tolerance of OIH, which is a state of hypersensitivity to painful stimuli associated with opioid therapy, resulting in exacerbation of pain sensation rather than relief of pain.

A comprehensive review of opioid-induced hyperalgesia.

Clinicians should suspect OIH when opioid treatment's effect seems to wane in the absence of disease progression, particularly if found in the context of unexplained pain reports or diffuse allodynia unassociated with the original pain, and increased levels of pain with increasing dosages.

The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain

The successful use of low-dose ketamine infusion for the treatment of opioid-induced hyperalgesia in a 38-year-old woman presenting with psychosocial suffering and high opioid requirement secondary to pain from a poorly differentiated neuroendocrine tumor is reported.

Opioid-induced hyperalgesia: fact or fiction?

Clinical evidence suggests that opioids can elicit increased sensitivity to noxious stimuli suggesting that the administration of opioids can activate both pain inhibitory and pain facilitatory systems.

Fentanyl-induced neurotoxicity and paradoxic pain.

Two Cases of Opioid-Induced Hyperalgesia in Cancer Patients Treated with Opioids for Pain Management

Two clinical cases of suc-cessful management of OIH in cancer pain patients that were treated with opioids are reported.

Supraspinal And Spinal Mechanisms Of Morphine-Induced Hyperalgesia

The current studies were performed with the goal of elucidating the precise location of regulatory action of this sexand dosedependent state of morphine hyperalgesia, and identifying the non-opioid systems that contribute to this state are located supraspinally or spinally.

Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management.

The distinction between OIH, tolerance and withdrawal should be made in both the basic and clinical science literature so as to help translate findings to the clinical phenomenon and to help determine the best strategies to prevent or treat OIh.

The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.

The use of very-low-dose methadone in conjunction with adjuvant haloperidol resulted in excellent pain control without dose escalation or opioid-induced hyperalgesia, for both cancer and noncancer diseases.

Postoperative hyperalgesia-A clinically applicable narrative review.




Hyperalgesia: an emerging iatrogenic syndrome.

Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.

In most patients with cancer pain referred for poor pain control and/or adverse effects, switching to oral methadone is a valid therapeutic option, and higher doses of methad one are necessary with respect to the equianalgesic calculated dose ratios previously published.

Methadone titration in opioid-resistant cancer pain.

This method of methadone titration often results in improved pain control in patients with morphine resistance or intolerance, and requires careful titration in a specialist inpatient unit as there is no reliable formula for dose equivalence.

Rapid switching from morphine to methadone in cancer patients with poor response to morphine.

A rapid substitution of morphine with methadone using an initial fixed ratio of 5:1 is a safe and effective method for improving the balance between analgesia and adverse effects in cancer patients with poor morphine response.

Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?

The results of this study confirm that methadone is a potent opioid, more potent than believed, especially in patients who are tolerant to high doses of opioids.

Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?

Identification of risk factors for the development of OIN can help in its prevention and improve the quality of life in advanced cancer patients, and strategies for its treatment can be implemented with encouraging results.